[Federal Register Volume 60, Number 57 (Friday, March 24, 1995)]
[Notices]
[Page 15569]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-7311]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[CRADA 95-002]


National Institute for Occupational Safety and Health; 
Cooperative Research and Development Agreement

AGENCY: Centers for Disease Control and Prevention (CDC), Public Health 
Service, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), National 
Institute for Occupational Safety and Health (NIOSH), announces the 
opportunity for potential collaborators to enter into a Cooperative 
Research and Development Agreement (CRADA) to develop an inexpensive 
aerosol generator to produce a solid sodium chloride aerosol with a CMD 
between 0.06 and 0.11 <greek-m>m and a geometric standard deviation of 
1.80 as measured by a differential mobility particle sizer.
    It is anticipated that all inventions which may arise from this 
CRADA will be jointly owned. The collaborator(s) with whom the CRADA is 
made will have an option to negotiate an exclusive or nonexclusive 
royalty-bearing license. The CRADA will be executed for a 2-year period 
with the possibility of renewal for another 2-year period.
    Because CRADAs are designed to facilitate the development of 
scientific and technological knowledge into useful, marketable 
products, a great deal of freedom is given to Federal agencies in 
implementing collaborative research. The CDC may accept staff, 
facilities, equipment, supplies, and money from the other participants 
in a CRADA; CDC may provide staff, facilities, equipment, and supplies 
to the project. There is a single restriction in this exchange: CDC MAY 
NOT PROVIDE FUNDS to the other participants in a CRADA. This 
opportunity is available until 30 days after publication of this 
notice. Respondents may be provided a longer period of time to furnish 
additional information if CDC finds this necessary.

FOR FURTHER INFORMATION CONTACT:

Technical

    Ernest S. Moyer, Ph.D., Protective Equipment Section, Protective 
Technology Branch, Division of Safety Research, NIOSH, CDC, ALOSH 
Laboratories, 944 Chestnut Ridge Road, Mailstop P119 (Room 142), 
Morgantown, West Virginia 26505, telephone (304) 285-5962, FAX (304) 
285-6047.

Business

    Theodore F. Schoenborn, Technology Transfer Coordinator, NIOSH, 
CDC, 4676 Columbia Parkway, Mailstop R2, Cincinnati, Ohio 45226, 
telephone, (513) 841-4305, FAX (513) 841-4500.

SUPPLEMENTARY INFORMATION: The inexpensive aerosol generator to produce 
solid sodium chloride aerosol of the desired size and size distribution 
will be used in determining filter penetration in accordance with 
NIOSH-proposed new respirator regulations 42 CFR Part 84. The 
generation system needs to be able to reproducibly produce sodium 
chloride aerosol of known size (0.06-0.11 <greek-m>m CMD) and with a 
standard deviation of <ls-thn-eq>1.80. The aerosol's concentration 
needs to be >10 mg/m<SUP>3 and can be as high as 200 mg/m<SUP>3. The 
collaborator(s) and NIOSH will jointly perform the research aimed at 
development of a commercially inexpensive system to achieve instrument 
ruggedness and lowest possible cost per unit system. NIOSH will provide 
technical expertise, consultation and guidance, system specifications, 
verification of system integrity, and product evaluation and testing. 
Since this CRADA involves the bringing together of diverse 
technologies, a consortium of collaborators will be considered. 
Technology derived under this CRADA will not be used for standards 
setting.
    Applicants will be judged according to the following criteria:
    1. Adequacy and technical capabilities to develop the desired 
technologies and product;
    2. Ability to develop, produce, market, and support commercial 
aerosol generation systems;
    3. Evidence of technical credibility; and
    4. Ability to complete the CRADA in a timely fashion.
    This CRADA is proposed and implemented under the 1986 Federal 
Technology Transfer Act: Pub. L. 99-502.
    The responses must be made to: Theodore F. Schoenborn, Technology 
Transfer Coordinator, National Institute for Occupational Safety and 
Health, CDC, 4676 Columbia Parkway, Mailstop R2, Cincinnati, Ohio 
45226.

    Dated: March 17, 1995.
Linda Rosenstock,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention (CDC).
[FR Doc. 95-7311 Filed 3-23-95; 8:45 am]
BILLING CODE 4163-19-P